ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,852 | -22.7% | 80 | 0.0% | 0.00% | – |
| Q2 2023 | $3,690 | +46025.0% | 80 | -61.9% | 0.00% | – |
| Q1 2023 | $8 | -20.0% | 210 | 0.0% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 210 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | -98.4% | 210 | -97.5% | 0.00% | -100.0% |
| Q2 2022 | $509,000 | +1541.9% | 8,533 | +1870.7% | 0.00% | – |
| Q1 2022 | $31,000 | -75.8% | 433 | -76.3% | 0.00% | -100.0% |
| Q4 2021 | $128,000 | -16.9% | 1,829 | +7.5% | 0.00% | 0.0% |
| Q3 2021 | $154,000 | -57.2% | 1,702 | -54.9% | 0.00% | -50.0% |
| Q2 2021 | $360,000 | -39.5% | 3,772 | -27.8% | 0.00% | -50.0% |
| Q1 2021 | $595,000 | -17.7% | 5,222 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $723,000 | +366.5% | 5,222 | +177.0% | 0.01% | +400.0% |
| Q3 2020 | $155,000 | +355.9% | 1,885 | +333.3% | 0.00% | – |
| Q2 2020 | $34,000 | +100.0% | 435 | +13.0% | 0.00% | – |
| Q1 2020 | $17,000 | +41.7% | 385 | +35.1% | 0.00% | – |
| Q4 2019 | $12,000 | 0.0% | 285 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -14.3% | 285 | +32.6% | 0.00% | – |
| Q2 2019 | $14,000 | -6.7% | 215 | 0.0% | 0.00% | – |
| Q1 2019 | $15,000 | +66.7% | 215 | 0.0% | 0.00% | – |
| Q4 2018 | $9,000 | -43.8% | 215 | 0.0% | 0.00% | – |
| Q3 2018 | $16,000 | -23.8% | 215 | -21.8% | 0.00% | – |
| Q2 2018 | $21,000 | +133.3% | 275 | +57.1% | 0.00% | – |
| Q1 2018 | $9,000 | -50.0% | 175 | -35.2% | 0.00% | – |
| Q1 2017 | $18,000 | -48.6% | 270 | -46.0% | 0.00% | – |
| Q4 2016 | $35,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2016 | $35,000 | +133.3% | 500 | +66.7% | 0.00% | – |
| Q2 2016 | $15,000 | -21.1% | 300 | 0.0% | 0.00% | – |
| Q1 2016 | $19,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |